Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation

Developmental Neurobiology

Volumn 72, Issue 5, 2012, Pages 713-728

  De Angelis, Federica ^a   Bernardo, Antonietta ^b   Magnaghi, Valerio ^c   Minghetti, Luisa ^b   Tata, Ada Maria ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Muscarinic receptors; Myelin proteins; Oligodendrocytes; Proliferation; Survival

Indexed keywords

CONNEXIN 32; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; MESSENGER RNA; MUSCARINIC M1 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR; MYELIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEOLIPID PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; MITOGENICITY; NONHUMAN; OLIGODENDROGLIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; STEM CELL;

ANIMALS; ANIMALS, NEWBORN; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; NERVE FIBERS, MYELINATED; OLIGODENDROGLIA; PRIMARY CELL CULTURE; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTORS, MUSCARINIC; STEM CELLS;

EID: 84859492260     PISSN: 19328451     EISSN: 10974695     Source Type: Journal    
DOI: 10.1002/dneu.20976     Document Type: Article

References (78)

1. Anton ES, Marchionni MA, Lee P, Rakic KF. 1997. Role of GGF/neuregulin signaling in interactions between migrating neurons and radial glia in the developing cerebral cortex. Development 124: 3501-3510.
2. Araque A, Sanzgiri RP, Parpura VHaydon PG. 1999. Astrocyte-induced modulation of synaptic transmission. Can J Physiol Pharmacol 77: 699-706.
3. Augusti-Tocco G, Biagioni S, Tata AM. 2006. Acetylcholine and regulation of gene expression in developing systems. J Mol Neurosci 30: 45-48.
4. Barres BA. 1997. Neuron-glial interactions. In: Cowan WM, Jessell TM, Zipursky SL, editors. Molecular and Cellular Approaches to Neural Development. New York: Oxford University Press, pp 64-107.
5. Bernardini N, De Stefano ME, Tata AM, Biagioni S, Augusti-Tocco G. 1998. Neuronal and non-neronal cell population of the avian dorsal root ganglia express muscarinic acetylcholine receptors. Int J Dev Neurosci 16: 365-377.
6. Bernardo A, Agresti C, Levi G. 1997. HIV-gp120 affects the functional activity of oligodendrocytes and their susceptibility to complement. J Neurosci Res 50: 946-957.
7. Bernardo A, Bianchi D, Magnaghi V, Minghetti L. 2009. Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells. J Neuropathol Exp Neurol 68: 797-808.
8. Bernardo A, Greco A, Levi G, Minghetti L. 2003. Differential lipid peroxidation, Mn superoxide and bcl-2 expression contribute to the maturation-dependent vulnerability of oligodendrocytes to oxidative stress. J Neuropathol Exp Neurol 62: 509-519.
9. Biagioni S, Tata AM, De Jaco A, Augusti-Tocco G. 2000. Acetylcholine synthesis and neuron differentiation. Int J Dev Biol 44: 689-697.
10. Biagioni S, Tata AM, De Jaco A, Augusti-Tocco G. 2002. Acetylcholine and regulation of gene expression in nerve system development. Curr Top Neurochem 3: 177-188.
11. Brattelid T, Tveit K, Birkeland JAK, Sjaastad I, Qvigstad E, Krobert KA, Hussain PI, et al. 2007. Expression of mRNA encoding G protein-coupled receptors involved in congestive heart failure. Basic Res Cardiol 102: 198-208.
12. Campagnoni AT, Campagnoni CW. 2004. Myelin basic protein gene. In: Lazzarini RA, editor. Myelin Biology and Disorders. San Diego, CA: Elsevier Academic, pp 387-400.
13. Canoll PD, Musacchio JM, Hardy R, Reynolds R, Marchionni MA, Salzer JL. 1996. GGF/Neuroegulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitor. Neuron 17: 229-243.
14. Cohen RI, Almazan G. 1994. Rat oligodendrocytes express muscarinic receptors coupled to phosphoinositide hydrolysis and adenylyl ciclase. Eur J Neurosci 6: 1213-1224.
15. Cohen RI, Molina-Holgado E, Almazan G. 1996. Carbachol stimulates c-fos expression and proliferation in oligodendrocytes progenitors. Mol Brain Res 43: 193-201.
16. Corfas G, Roy K, Buxbaum JD. 2004. Neuregulin 1-ErbB signaling and the molecular/cellular basis of schizophrenia. Nature Neurosci 7: 575-580.
17. Cui QL, Fogle E, Almazan G. 2006. Muscarinic acetylcholine receptors mediate survival through Src-like tyrosine kinase and PI3K/Akt pathways. Neurochem Int 48: 383-393.
18. De Simone R, Ajmone-Cat MA, Carnevale D, Minghetti L. 2005. Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures. J Neuroinflammation 25: 1-10.
19. Dubois-Dalcq M, Behar T, Hudson L, Lazzarini RA. 1986. Emergence of three myelin proteins in oligodendrocytes cultured without neurons. J Cell Biol 102: 384-392.
20. Eglen RM. 2005. Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function. Autonom Autocoid Pharmacol 26: 219-233.
21. Felder CC, Bymaster FP, Ward J, Delapp N. 2000. Therapeutic opportunities for muscarinic receptors in central nervous system. J Med Chem 43: 4333-4353.
22. Garcia-Abreu J, Moura Neto V, Carvalho SL, Cavalcante LA. 1995. Regionally specific properties of midbrain glia: Interactions with midbrain neurons. J Neurosci Res 40: 417-477.
23. Gomes FCA, Spohr TCLS, Martinez R, Moura Neto V. 2001. Cross-talk between neurons and glia: Highlights on soluble factors. Braz J Med Biol. Res 34: 611-620.
24. Grando SA, Pittelkow MR, Schallreuter KU. 2006. Adrenergic and Cholinergic Control in the Biology of Epidermis: Physiological and Clinical Significance. J Inv Dermatol 126: 1948-1965.
25. Guizzetti M, Costa P, Peters J, Costa LG, 1996. Acetylcholine as a mitogen: Muscarinic receptor-mediated proliferation of rat astrocytes and human astrocytoma cells. Eur J Pharmacol 297: 265-273.
26. Jian-Guo H, Sai-Li F, Kai-Hua Z, Yiu L, Pei-Hua L, Xico-Ming X. 2004. Differential gene expression in neural stem cells and oligodendrocyte precursor cell: A cDNA microarray analysis. J Neurosci Res 78: 637-646.
27. Kahn DW, Morell P. 1988. Phosphatidic acid and phosphoinositide turnover in myelin and its stimulation by acetylcholine. J Neurochem 50: 1542-1550.
28. Kastritsis CH, McCarthy KD. 1993. Oligodendroglial lineage cells express neuroligand receptors. GLIA 8: 106-113.
29. Kawashima K, Fuji T. 2008. Basic and clinical aspects of non-neuronal acetylcholine: Overview of non-neuronal cholinergic systems and their biological significance. JPharmacol Sci 106: 167-173.
30. Kettenmann H, Ransom B. 2005. Neuroglia, 2nd ed. New York: Oxford University Press.
31. Langmead CJ, Watson J, Reavill C. 2008. Muscarinic acetylcholine receptors as CNS drug targets. Pharmacol Ther 117: 232-243.
32. Larocca JN, Leeden RW, Dvorkin B, Makman MH. 1987. Muscarinic receptor binding and muscarinic receptor mediated inhibition of adenilate cyclase in rat brain myelin. J Neurosci 7: 3869-3876.
33. Larocca JN, Almazan G. 1997. Acetylcholine agonists stimulate mitogen-activated protein-kinase in oligodendrocyte progenitors by muscarinic receptors. J Neurosci Res 50: 743-754.
34. Lauder JM. 1993. Neurotransmitters as growth regulatory signal: Role of receptors and second messangers. TINS 16: 233-239.
35. Levi G, Aloisi F, Wilkin GP. 1987. Differentiation of cerebellar bipotential glial precursors into oligodendrocytes in primary culture: Developmental profile of surface antigens and mitotic activity. J Neurosci Res 18: 407-417.
36. Loreti S, Vilaró MT, Visentin S, Rees H, Levey AI, Tata AM. 2006. Rat Schwann cells express M1-M4 muscarinic receptor subtypes. J Neurosci Res 84: 97-105.
37. Loreti S, Ricordy R, De Stefano ME, Augusti-Tocco G, Tata AM. 2007. Acetylcholine inhibits cell cycle progression in rat Schwann cells by activation of the M2 receptor subtype. Neuron Glia Biol 4: 269-279.
38. Loreti S, Ricordy R, Magnaghi V, Augusti-Tocco G, Tata AM. 2007a. Acetylcholine controls Schwann cell transition from proliferating to mature phenotype, counteracting NRG1 action. International Proceedings:VIII European Meeting of the Glial Cells in Health and Disease, Medimond Ed, 47-53.
39. Ma W, Li BS, Zhang L, Pant H. 2004. Signaling cascades implicated in muscarinic regulation of proliferation of neural stem and progenitor cells. Drug News Perspect, 17: 258-266.
40. McArthur RA, Gray J, Schreiber R. 2010. Cognitive effects of muscarinic M1 functional agonists in non-human primates and clinical trials. Curr Opin Investig Drugs 11: 740-760.
41. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol. 85: 890-902.
42. Magnaghi V, Ballabio M, Cavarretta I, Froestl W Lambert J, Zucchi M, Melcangi RC. 2004. GABA-B receptor in Schwann cells influence proliferation and myelin protein expression. Eur J Neurosci 19: 2641-2649.
43. Magnaghi V, Procacci P, Tata AM. 2009. Novel pharmacological approaches to Schwann cells as neuroprotective agent for peripheral nerve regeneration. Int. Rev. Neurobiol 87: 295-315.
44. Molina-Holgado E, Khorchid A, Liu HN, Almazan G. 2003. Regulation of muscarinic receptor function in developing oligodendrocytes by agonistic exposure. Br J Pharmacol 138: 47-56.
45. Mossman T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
46. Murphy S, Pearce B, Morrow C. 1986. Astrocytes have both M1 and M2 muscarinic receptor subtypes. Brain Res Jan 29: 177-180.
47. Park SK, Miller R, Crane I, Vartanian T. 2001. The ErbB2 gene is required for the development of terminally differentiated spinal cord oligodendrocytes. J Cell Biol 154: 1245-1258.
48. Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J, Capon DJ. 1987. Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. Embo J 6: 3923-3929.
49. Pfrieger FW, Barres BA. 1997. Synaptic efficacy enhanced by glial cells in vitro. Science 277: 1684-1686.
50. Proskocil BJ, Harmanjatinder SS, Yibing J, Savchenk V, Blakely RD, Lindstrom J, Spindel ER. 2004. Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Endocrinol 145: 2498-2506.
51. Ragheb F, Molina-Holgado E, Cui QL, Khorchid A, Liu HN, Larocca JN, Almazan G. 2001. Pharmacologicaland fuctional characterization of muscarinic receptor subtypes in developing oligodendrocytes. J Neurochem 77: 1396-1406.
52. Ritchie T, Cole R, Kim HS, de Vellis J, Noble EP. 1987. Inositol phospholipids hydrolysis in cultured astrocytes and oligodendrocytes. Life Sci 41: 31-39.
53. Rogers SW, Gregori NZ, Carlson N, Gahring LC, Noble M. 2001. Neuronal nicotinic acetylcholine receptor expression by O2A/oligodendrocytes progenitor cells. Glia 33: 306-313.
54. Roy K, Murtie JC, El-Khodor BF, Edgar N, Sardi SP, Hooks BM, Benoit-Marand M, et al. 2007. Loss of ErbB signalling in oligodendrocytes alters myelin and dopaminergic function, a potenzial mechanism for neuropsychiatric disorders. PNAS 104: 8181-8136.
55. Salani M, Anelli T, Augusti-Tocco G, Lucarini E, Mozzetta C, Poiana G, Tata AM, et al. 2009. Acetylcholine induced neuronal differentiation: Muscarinic receptor activations regulates EGR-1 and REST expression in neuroblastoma cells. J Neurochem 108: 821-834.
56. Schmucker J, Ader M, Brockschnieder D, Brodarac A, Bartsch U, Riethmacher D. 2003. ErbB3 is dispensable for oligodendrocyte development in vitro and in vivo. Glia 44: 67-75.
57. Simons M, Trajkovic K. 2006. Neuron-glia communication in the control of oligodendrocyte function and myelin. JCell Sci 119: 4381-4389.
58. Smith-Slatas C, Barbarese E. 2000. Myelin basic protein gene dosage effects in the PNS. Mol Cell Neurosci 15: 343-354.
59. Sommer I, Schachner M. 1981. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: An immunocytological study in the central nervous system. Dev Biol 83: 311-327.
60. Stallcup WB. 1981. The NG2 antigen, a putative lineage marker: Immunofluorescent localization in primary cultures of rat brain. Dev Biol 83: 154-165.
61. Stevens B, Fields RD. 2000. Response of Schwann cells to action potentials in development. Science 287: 2267-2270.
62. Stidworthy MF, Genoud S, Li WW, Leone DP, Mantei N, Suter U, Franklin RJM. 2004. Notch1 and Jagged 1 are expressed after CNS demyelination, but are not a major rate-determining factor during re-myelination. Brain 127: 1928-1941.
63. Tata AM, Vilaró MT, Mengod G. 2000. Muscarinic receptors subtypes expression in rat and chick dorsal root ganglia. Brain Res Mol Brain Res 82: 1-10.
64. Tata AM, Cursi S, Biagioni S, Augusti-Tocco G. 2003. Cholinergic modulation of neurofilamente expression and neurite outgrowth in chick sensory neurons. J Neurosci Res 73: 227-234.
65. Tata AM. 2008. Muscarinic acetylcholine receptors: New potential therapeutic targets in antinociception and in cancer therapy. Rec Pat CNS Drug Discov 2: 94-103.
66. Tata AM, Calogero A. 2010. Muscarinic receptors and cancer: Possible implications in tumors of the nervous system. Curr Trends Neurol 4: 23-31.
67. Tracey KJ. 2002. The inflammatory reflex. Nature 420: 853-859.
68. Taveggia C, Thaker P, Petrylak A, Caporaso GL, Toews A, Falls DL, Einheber S, et al. 2008. Type III neuregulin-1 promotes oligodendrocyte myelination. Glia 56: 283-294.
69. Taveggia C, Feltri LM, Wrabetz L. 2010. Signals to promote myelin formation and repair. Nat Rev Neurol 6: 276-287.
70. Ullian EM, Christopherson KS, Barres B. 2004. Role for glia in synaptogenesis. Glia 47: 209-226.
71. Van der Zee EA, De Jong GI, Strosberg AD, Luiten PGM. 1993. Muscarinic acetylcholine receptor-expression in astrocytes in the cortex of young and aged rats. Glia 8: 42-50.
72. Verkhratsky A. 2010. Physiology of neuronal-glial networking. Neurochem Int 57: 332-343.
73. Verkhratsky A, Toescu EC. 2006. Neuronal-glia networks as substrate for CNS integration. J Cell Mol Med 10: 869-879.
74. Weiner JA, Fukushima N, Contos J, Scherer S, Chun J. 2001. Regulation of Schwann cells morphology and adhesion by receptor mediated lysophosphatidic acid signalling. J Neurosci 21: 7069-7078.
75. Wess J. 2004. Muscarinic acetylcholine receptor knockout mice: Novel phenotypes and clinical implications. Ann Rev Pharmacol Toxicol 44: 423-450.
76. Wessler I, Kilbinger H, Bittinger F, Unger R, Kirkpatrick CJ. 2001. The biological role of non neuronal acetylcholine in plants and humans. J Pharmacol 85: 2-10.
77. Zhang Y, Argaw AT, Gurfein BT, Zameer A, Snyder BJ, Ge C, Lu QR, et al. 2009. Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination. Proc Natl Acad Sci 106: 19162-19167.
78. Zhou C, Wen ZX, Shi DM, Xie ZP. 2004. Muscarinic acetylcholine receptors involved in the regulation of neural stem cell proliferation and differentiation in vitro. Cell Biol Inter 28: 63-67.